ARYA Sciences Acquisition Corp IV

ARYA Sciences Acquisition Corp IV, trading under the ticker ARYD, is a blank-check company sponsored by ARYA Sciences Holdings IV LLC, an affiliate of healthcare-focused investment firm Perceptive Advisors. The SPAC completed its initial public offering in 2021 and targets opportunities in the life sciences and biotechnology sector, consistent with the broader ARYA Sciences franchise, which has sponsored multiple SPACs focused on healthcare innovation. As of its 10-Q filing with the SEC on November 9, 2023, ARYD remained in the business combination search phase, having not yet announced or closed an acquisition. For complete filing history, financial data, and real-time deal tracking on ARYD and hundreds of other active SPACs, sign up for full access at SpacDesk.